Evidence map›Paper›PMID 29342233›Full record

ArticleBioinformatics (Oxford, England)2018

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction.

Paul Deveau, Leo Colmet Daage, Derek Oldridge, Virginie Bernard, Angela Bellini, Mathieu Chicard, Nathalie Clement, Eve Lapouble, Valerie Combaret, Anne Boland and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches.International journal of environmental research and public health · 2023
    Article
  11. Accurate Identification of Subclones in Tumor Genomes.Molecular biology and evolution · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. The Architecture of a Precision Oncology Platform.Advances in experimental medicine and biology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Paul DeveauInstitut Curie, PSL Research University, Mines Paris Tech, INSERM U900, Paris 75005, France.
Leo Colmet DaageDépartement de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Derek OldridgeDivision of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Virginie BernardInstitut Curie, PSL Research University, NGS platform ICGex, Paris 75005, France.
Angela BelliniDépartement de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Mathieu ChicardDépartement de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Nathalie ClementDépartement de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Eve LapoubleUnité de Génétique Somatique, Institut Curie, PSL Research University, Paris 75005, France.
Valerie CombaretCentre Léon-Bérard Laboratoire de Recherche Translationnelle, Lyon, France.
Anne BolandCentre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, CEA, Evry 91057, France.
Vincent MeyerCentre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, CEA, Evry 91057, France.
Jean-Francois DeleuzeCentre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, CEA, Evry 91057, France.
Isabelle Janoueix-LeroseyInstitut Curie, PSL Research University, INSERM U830, SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Equipe labellisée Ligue Nationale contre le cancer, Paris 75005, France.
Emmanuel BarillotInstitut Curie, PSL Research University, Mines Paris Tech, INSERM U900, Paris 75005, France.
Olivier DelattreInstitut Curie, PSL Research University, INSERM U830, SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Equipe labellisée Ligue Nationale contre le cancer, Paris 75005, France.
John M MarisDivision of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Gudrun SchleiermacherDépartement de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Valentina BoevaInstitut Curie, PSL Research University, Mines Paris Tech, INSERM U900, Paris 75005, France.
Inserm · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRChildren's Hospital of Philadelphia · USUniversité Paris Sciences et Lettres · FRCentre Léon Bérard · FRCentre National de la Recherche Scientifique · FRUniversité Paris-Sud · FR

Funding

NCI NIH HHS HHSN261200800001EWorldwide Cancer Research 16-1294
6 · The paper itself

Abstract

Motivation: In cancer, clonal evolution is assessed based on information coming from single nucleotide variants and copy number alterations. Nonetheless, existing methods often fail to accurately combine information from both sources to truthfully reconstruct clonal populations in a given tumor sample or in a set of tumor samples coming from the same patient. Moreover, previously published methods detect clones from a single set of variants. As a result, compromises have to be done between stringent variant filtering [reducing dispersion in variant allele frequency estimates (VAFs)] and using all biologically relevant variants. Results: We present a framework for defining cancer clones using most reliable variants of high depth of coverage and assigning functional mutations to the detected clones. The key element of our framework is QuantumClone, a method for variant clustering into clones based on VAFs, genotypes of corresponding regions and information about tumor purity. We validated QuantumClone and our framework on simulated data. We then applied our framework to whole genome sequencing data for 19 neuroblastoma trios each including constitutional, diagnosis and relapse samples. We confirmed an enrichment of damaging variants within such pathways as MAPK (mitogen-activated protein kinases), neuritogenesis, epithelial-mesenchymal transition, cell survival and DNA repair. Most pathways had more damaging variants in the expanding clones compared to shrinking ones, which can be explained by the increased total number of variants between these two populations. Functional mutational rate varied for ancestral clones and clones shrinking or expanding upon treatment, suggesting changes in clone selection mechanisms at different time points of tumor evolution. Availability and implementation: Source code and binaries of the QuantumClone R package are freely available for download at https://CRAN.R-project.org/package=QuantumClone. Contact: gudrun.schleiermacher@curie.fr or valentina.boeva@inserm.fr. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

Clonal EvolutionDNA Copy Number VariationsSoftwareCluster AnalysisDNA Mutational AnalysisGene FrequencyHigh-Throughput Nucleotide SequencingHumansMolecular TypingMutationNeoplasmsWhole Genome Sequencing

Identifiers

PMID29342233
PMCPMC5972665
OpenAlexW2782970566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.